| __timestamp | Jazz Pharmaceuticals plc | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 2999000 |
| Thursday, January 1, 2015 | 449119000 | 10393000 |
| Friday, January 1, 2016 | 502892000 | 15994000 |
| Sunday, January 1, 2017 | 544156000 | 26975000 |
| Monday, January 1, 2018 | 683530000 | 39509000 |
| Tuesday, January 1, 2019 | 736942000 | 48869000 |
| Wednesday, January 1, 2020 | 854233000 | 42510000 |
| Friday, January 1, 2021 | 1451683000 | 46105000 |
| Saturday, January 1, 2022 | 1416967000 | 50513000 |
| Sunday, January 1, 2023 | 1343105000 | 51292000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Jazz Pharmaceuticals and Wave Life Sciences, two prominent players, exhibit contrasting trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Jazz Pharmaceuticals, with a robust growth trajectory, saw its SG&A expenses surge by over 230%, peaking at approximately $1.45 billion in 2021. This reflects their aggressive expansion and strategic investments. In contrast, Wave Life Sciences, a smaller entity, experienced a more modest increase of around 1,600%, reaching about $51 million in 2023. This disparity highlights the scale and strategic priorities of each company. Jazz's substantial spending underscores its market dominance, while Wave's cautious approach suggests a focus on sustainable growth. These insights offer a window into the financial strategies shaping the pharmaceutical industry today.
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Geron Corporation or Wave Life Sciences Ltd.